Invesco’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-2,009
| Closed | -$15.8K | – | 3906 |
|
2023
Q4 | $15.8K | Sell |
2,009
-517
| -20% | -$4.07K | ﹤0.01% | 3798 |
|
2023
Q3 | $11.2K | Hold |
2,526
| – | – | ﹤0.01% | 3850 |
|
2023
Q2 | $87.9K | Buy |
2,526
+150
| +6% | +$5.22K | ﹤0.01% | 3736 |
|
2023
Q1 | $51.8K | Buy |
2,376
+394
| +20% | +$8.59K | ﹤0.01% | 3737 |
|
2022
Q4 | $42.8K | Sell |
1,982
-254
| -11% | -$5.49K | ﹤0.01% | 3897 |
|
2022
Q3 | $55K | Buy |
2,236
+309
| +16% | +$7.6K | ﹤0.01% | 3885 |
|
2022
Q2 | $39K | Buy |
1,927
+400
| +26% | +$8.1K | ﹤0.01% | 3976 |
|
2022
Q1 | $54K | Sell |
1,527
-10
| -0.7% | -$354 | ﹤0.01% | 3886 |
|
2021
Q4 | $42K | Sell |
1,537
-30
| -2% | -$820 | ﹤0.01% | 3958 |
|
2021
Q3 | $68K | Buy |
1,567
+394
| +34% | +$17.1K | ﹤0.01% | 3948 |
|
2021
Q2 | $58K | Buy |
+1,173
| New | +$58K | ﹤0.01% | 3914 |
|